• Info
  • Significant Ownership

Significant Ownership of Hoche Partners Pharma Holding S.A.

Signature - Title
/s/ Roman Sokolowski - Roman Sokolowski/Director
Location
Luxembourg, Luxembourg
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Hoche Partners Pharma Holding S.A..

Notify me when Hoche Partners Pharma Holding S.A. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Hoche Partners Pharma Holding S.A.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PROCF Procaps Group, S.A. Ordinary Shares, nominal value of $0.01 per share 84% $2,867,018,231 2,077,549,443 Hoche Partners Pharma Holding S.A. 16 Apr 2025

Schedules 13D/G Reported by Hoche Partners Pharma Holding S.A.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.